However, expression in the NAU was predicted to be driven by ALDH1A2 and MFAP4 (Figure 4C)—genes that are both notoriously downregulated in other genitourinary malignancies compared to normal samples [31,32], likely suggesting tumor-suppressive roles. The gene discussed is ALDH1A2; the disease is neoplasm.